Senseonics Holdings (SENS) Cash & Current Investments (2014 - 2026)
Senseonics Holdings (SENS) posted quarterly Cash & Current Investments of $64.3 million for Q1 2026, up 62.32% year-over-year from $39.6 million in Q1 2025, and up 58.63% quarter-over-quarter from $40.5 million in Q4 2025.
Senseonics Holdings (SENS) Cash & Current Investments (2014 - 2026) Analysis & Trends
Senseonics Holdings (SENS) has reported Cash & Current Investments for 13 consecutive years, with $64.3 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Cash & Current Investments rose 62.32% year-over-year to $64.3 million; the TTM figure through Mar 2026 stood at $64.3 million (up 62.32% YoY), while the FY2025 annual figure was $40.5 million, down 45.87% from the prior year.
- Cash & Current Investments advanced to $64.3 million in Q1 2026 per SENS's latest filing, from $40.5 million in the prior quarter.
- Across five years, Cash & Current Investments topped out at $281.7 million in Q3 2022 and bottomed at $39.6 million in Q1 2025.
- Historically, Cash & Current Investments has averaged $134.2 million across 5 years, with a median of $111.0 million in 2025.
- Annual changes were most pronounced in 2022 — Cash & Current Investments soared 1547.1% — and 2024, when it sank 61.81%.
- Senseonics Holdings' Cash & Current Investments stood at $109.4 million in 2022, then climbed by 0.09% to $109.5 million in 2023, then slumped by 31.56% to $74.9 million in 2024, then plunged by 45.87% to $40.5 million in 2025, then jumped by 58.63% to $64.3 million in 2026.
- Business Quant data shows SENS's Cash & Current Investments at $64.3 million in Q1 2026, $40.5 million in Q4 2025, and $111.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.63 Bn | 194.02 Bn | 7.27 Bn | 5.60 Bn |
| 2 | Stryker | 127.42 Bn | 123.95 Bn | 4.50 Bn | 3.48 Bn |
| 3 | Medtronic | 118.97 Bn | 109.75 Bn | 6.41 Bn | 9.22 Bn |
| 4 | Boston Scientific | 73.39 Bn | 72.85 Bn | 3.85 Bn | 539.00 Mn |
| 5 | Edwards Lifesciences | 51.97 Bn | 47.72 Bn | 1.35 Bn | 4.25 Bn |
| 6 | Dexcom | 34.32 Bn | 32.37 Bn | 830.00 Mn | 1.95 Bn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | 2.11 Bn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | 3.32 Bn |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn | 482.30 Mn |
| 10 | Senseonics Holdings | 515.38 Mn | 274.77 Mn | 8.56 Mn | 240.61 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 240.61 Mn |
| Mar 31, 2026 | 64.32 Mn |
| Dec 31, 2025 | 40.55 Mn |
| Sep 30, 2025 | 110.95 Mn |
| Jun 30, 2025 | 126.72 Mn |
| Mar 31, 2025 | 39.63 Mn |
| Dec 31, 2024 | 74.91 Mn |
| Sep 30, 2024 | 74.48 Mn |
| Jun 30, 2024 | 134.37 Mn |
| Mar 31, 2024 | 99.02 Mn |
| Dec 31, 2023 | 109.46 Mn |
| Sep 30, 2023 | 195.05 Mn |
| Jun 30, 2023 | 214.17 Mn |
| Mar 31, 2023 | 219.96 Mn |
| Dec 31, 2022 | 109.36 Mn |
| Sep 30, 2022 | 281.72 Mn |
| Jun 30, 2022 | 244.26 Mn |
| Mar 31, 2022 | 141.77 Mn |
| Dec 31, 2021 | 100.71 Mn |
| Sep 30, 2021 | 142.78 Mn |